Steatotic Liver Disease, also known as fatty liver disease, is related to metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis. An important gene associated with Steatotic Liver Disease is NAFLD1 (Fatty Liver Disease 1, Susceptiblity To), and among its related pathways/superpathways are Glucose / Energy Metabolism and Cell differentiation - expanded index. The drugs Entecavir and Simvastatin have been mentioned in the context of this disorder. Affiliated tissues include liver and skeletal muscle, and related phenotype is liver/biliary system.